Recombinant expression, purification, and characterization of Toxoplasma gondii adenosine kinase

被引:35
作者
Darling, JA
Sullivan, WJ
Carter, D
Ullman, B
Roos, DS
机构
[1] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA
[2] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA
基金
美国国家卫生研究院;
关键词
purine salvage; nucleoside metabolism; protein purification; enzyme kinetics; apicomplexan parasites;
D O I
10.1016/S0166-6851(99)00109-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toxoplasma gondii lacks the capacity to synthesize purines de novo, and adenosine kinase (AK)-mediated phosphorylation of salvaged adenosine provides the major route of purine acquisition by this parasite. T. gondii AK thus represents a promising target for rational design of antiparasitic compounds. In order to further our understanding of this therapeutically relevant enzyme, an AK cDNA from T. gondii was overexpressed in E. coli using the pBAce expression system, and the recombinant protein was purified to apparent homogeneity using conventional protein purification techniques. Kinetic analysis of TgAK revealed K-m values of 1.9 mu M for adenosine and 54.4 mu M for ATP, with a k(cat) of 26.1 min(-1). Other naturally occurring purine nucleosides, nucleobases, and ribose did not significantly inhibit adenosine phosphorylation. but inhibition was observed using certain purine nucleoside analogs. Adenine arabinoside (AraA), 4-nitrobenzylthioinosine (NBMPR), and 7-deazaadenosine (tubercidin) were all shown to be substrates of T. gondii AK. Transgenic AK knock-out parasites were resistant to these compounds in cell culture assays, consistent with their proposed action as subversive substrates in vivo. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 34 条
[1]   CLONING AND EXPRESSION OF THE HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE GENE FROM TRYPANOSOMA-BRUCEI [J].
ALLEN, TE ;
ULLMAN, B .
NUCLEIC ACIDS RESEARCH, 1993, 21 (23) :5431-5438
[2]  
Araujo F G, 1992, Int J Antimicrob Agents, V1, P153, DOI 10.1016/0924-8579(92)90002-9
[3]  
BENNETT LL, 1975, MOL PHARMACOL, V11, P803
[4]  
Brooks R. G., 1987, Antimicrobial Agents Annual, V2, P297
[5]  
CHABNER BA, 1996, GOODMAN GILMANS PHAR, P1247
[6]  
CHANG CH, 1980, J BIOL CHEM, V255, P2366
[7]   HIGH-LEVEL EXPRESSION IN ESCHERICHIA-COLI OF SOLUBLE, ENZYMATICALLY ACTIVE SCHISTOSOMAL HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE AND TRYPANOSOMAL ORNITHINE DECARBOXYLASE [J].
CRAIG, SP ;
YUAN, L ;
KUNTZ, DA ;
MCKERROW, JH ;
WANG, CC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2500-2504
[8]  
DEJONG JW, 1979, ANAL BIOCHEM, V101, P407
[9]   Insertional tagging, cloning, and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene - Use as a selectable marker for stable transformation [J].
Donald, RGK ;
Carter, D ;
Ullman, B ;
Roos, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) :14010-14019
[10]   THERAPEUTIC EFFICACY OF ALLOPURINOL IN PATIENTS WITH CHRONIC CHAGAS-DISEASE [J].
GALLERANO, RH ;
MARR, JJ ;
ROSA, RR .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1990, 43 (02) :159-166